Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
0.5858
-0.0212 (-3.49%)
At close: Feb 12, 2026, 4:00 PM EST
0.5839
-0.0019 (-0.32%)
After-hours: Feb 12, 2026, 7:56 PM EST

Jaguar Health Revenue

Jaguar Health had revenue of $3.08M in the quarter ending September 30, 2025, a decrease of -0.80%. This brings the company's revenue in the last twelve months to $11.79M, up 13.37% year-over-year. In the year 2024, Jaguar Health had annual revenue of $11.69M with 19.75% growth.

Revenue (ttm)
$11.79M
Revenue Growth
+13.37%
P/S Ratio
0.06
Revenue / Employee
$240,510
Employees
49
Market Cap
2.66M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202411.69M1.93M19.75%
Dec 31, 20239.76M-2.20M-18.36%
Dec 31, 202211.96M7.62M175.80%
Dec 31, 20214.34M-5.05M-53.81%
Dec 31, 20209.39M3.61M62.51%
Dec 31, 20195.78M1.36M30.77%
Dec 31, 20184.42M54.96K1.26%
Dec 31, 20174.36M4.22M2,981.61%
Dec 31, 2016141.52K-116.86K-45.23%
Dec 31, 2015258.38K--
Dec 31, 2014---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SciSparc1.31M
Onconetix1.22M
Scinai Immunotherapeutics1.15M
Lyra Therapeutics600.00K
HCW Biologics422.03K
Revenue Rankings